PMID- 21603246 OWN - NLM STAT- PubMed-not-MEDLINE DCOM- 20110714 LR - 20211020 IS - 1179-5549 (Electronic) IS - 1179-5549 (Linking) VI - 5 DP - 2011 TI - The role of T lymphocytes in cancer patients undergoing immunotherapy with autologous dendritic cells. PG - 107-15 LID - 10.4137/CMO.S6927 [doi] AB - INTRODUCTION: Cancer stems from mutations in specific genes that induce uncontrolled cell proliferation. Dendritic cells (DCs) are important immunologic cells and play a crucial role in the induction of an antitumour response. PATIENTS AND METHODS: We examined the immune response mediated by T lymphocytes, helper T cells, cytotoxic T cells, and regulatory T cells, as well as the cytokines [interleukin (IL)-2, IL-12, interferon (IFN)-gamma, tumour necrosis factor (TNF)-alpha and IL-10], produced by these cell populations, in cancer patients (N = 7) undergoing immunotheraphy with autologous DCs. RESULTS: We observed an initial increase in T helper cells (CD4+) expressing IL-2, IFN-gamma, IL-12, TNF-alpha, and IL-10 after initiation of treatment, with statistically significant for the cytokines IL-2, TNF-alpha and IL-10. A similar significant effect was observed for IL-2-expressing cytotoxic T cells (CD8+). The percentage of total T cells (CD3+) remained elevated throughout immunotherapy. Regulatory T cells (CD25+/FOXP3+) only showed high percentage of their maximum value when analyzed the pretreatment levels, with statistically significant. CONCLUSION: Immunotherapy with DCs stimulated the immune response, as evidenced by an increase in percent fluorescence of most cell populations investigated during the specified treatment period. FAU - Rodrigues, Claudia M AU - Rodrigues CM AD - Research Institute for Oncology-IPON, Federal University of the Triangulo Mineiro-UFTM, Uberaba, Minas Gerais, Brazil. FAU - Matias, Bruna F AU - Matias BF FAU - Murta, Eddie F C AU - Murta EF FAU - Michelin, Marcia A AU - Michelin MA LA - eng PT - Journal Article DEP - 20110425 PL - United States TA - Clin Med Insights Oncol JT - Clinical Medicine Insights. Oncology JID - 101525771 PMC - PMC3095027 OTO - NOTNLM OT - T cells OT - cancer OT - cytokines OT - dendritic cells OT - immunotherapy EDAT- 2011/05/24 06:00 MHDA- 2011/05/24 06:01 PMCR- 2011/04/25 CRDT- 2011/05/24 06:00 PHST- 2011/05/24 06:00 [entrez] PHST- 2011/05/24 06:00 [pubmed] PHST- 2011/05/24 06:01 [medline] PHST- 2011/04/25 00:00 [pmc-release] AID - cmo-2011-107 [pii] AID - 10.4137/CMO.S6927 [doi] PST - ppublish SO - Clin Med Insights Oncol. 2011;5:107-15. doi: 10.4137/CMO.S6927. Epub 2011 Apr 25.